Compare VOYA & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOYA | BRKR |
|---|---|---|
| Founded | 1975 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 7.0B |
| IPO Year | 2013 | 2000 |
| Metric | VOYA | BRKR |
|---|---|---|
| Price | $73.61 | $45.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $83.67 | $46.45 |
| AVG Volume (30 Days) | 820.5K | ★ 2.4M |
| Earning Date | 02-03-2026 | 11-03-2025 |
| Dividend Yield | ★ 2.55% | 0.44% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.82 | N/A |
| Revenue | ★ $8,088,000,000.00 | $3,438,900,000.00 |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | $5.02 | $1.23 |
| P/E Ratio | $12.66 | ★ N/A |
| Revenue Growth | 2.91 | ★ 6.10 |
| 52 Week Low | $52.43 | $28.53 |
| 52 Week High | $78.00 | $64.64 |
| Indicator | VOYA | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 51.48 |
| Support Level | $69.47 | $44.96 |
| Resistance Level | $71.78 | $47.88 |
| Average True Range (ATR) | 1.46 | 1.82 |
| MACD | 0.55 | -0.55 |
| Stochastic Oscillator | 77.55 | 2.89 |
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.